Industrial Microbiology Testing Services Market to Reach USD 8.6 Billion by 2032 | CAGR: 7.5% | DataHorizzon Research

DataHorizzon Research
DataHorizzon Research

Fort Collins, Colorado, Sept. 08, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Industrial Microbiology Testing Services Market Size, Share, Growth, Trends, Statistics Analysis Report, By Test Type, By Application, By Product Type (Reaction Consumables and Equipment & Systems), By Region And Segment Forecasts, 2023-2032."

According to DataHorizzon Research, The industrial microbiology testing services market size was USD 4.2 Billion in 2022 and is projected to grow to USD 8.6 Billion by 2023 at a CAGR of 7.5%. The increasing public concern for the safety of food & beverages products is propelling the adoption of the industrial microbiology testing services market. Also, the rising significance of the efficacy of pharmaceutical products across the globe due to the rapid spread of infectious diseases worldwide, like COVID-19 and its emerging variants, is fostering the growth of the industrial microbiology testing services market.

Microbiology is utilized for various methods by the pharmaceutical, food & beverage, and cosmetics sectors to reduce the risk of contamination in the products. Industrial microbiology entails using air control systems, incubators, microbial detection systems, culture tools, equipment, procedures, and filtering techniques. The rise in R&D investment and expansion in facilities by pharmaceutical and biotechnology firms for approval and launch of new drugs in the market is another prominent factor for the market’s growth.

Request Sample Report: https://datahorizzonresearch.com/request-sample-pdf/industrial-microbiology-testing-services-market-2381

Industrial Microbiology Testing Services Market Report Highlights:

  • The stem cells market is projected to attain a CAGR of 7.5% by 2032.

  • Sterility testing is at the forefront of the test type segment growth and is expected to continue its dominance. Growing applications in pharmaceutical and food & beverages industries are prominent factors for segment growth.

  • The pharmaceutical and biotechnology applications account for a significant position in the segment owing to the rise in approvals for stem cell therapies.

  • Reaction consumables are dominating in product type segment owing to the increased use of various reagents in the research and development for drug discovery.

  • North America is a dominant market for industrial microbiology testing services due to the presence of robust healthcare infrastructure and high investments in research and development. Besides, the rise in infectious diseases is a significant factor for market development in North America.